Page last updated: 2024-10-29

amrinone and Multiple Organ Failure

amrinone has been researched along with Multiple Organ Failure in 1 studies

Amrinone: A positive inotropic cardiotonic (CARDIOTONIC AGENTS) with vasodilator properties, phosphodiesterase 3 inhibitory activity, and the ability to stimulate calcium ion influx into the cardiac cell.
amrinone : A 3,4'-bipyridine substituted at positions 5 and 6 by an amino group and a keto function respectively. A pyridine phosphodiesterase 3 inhibitor, it is a drug that may improve the prognosis in patients with congestive heart failure.

Multiple Organ Failure: A progressive condition usually characterized by combined failure of several organs such as the lungs, liver, kidney, along with some clotting mechanisms, usually postinjury or postoperative.

Research Excerpts

ExcerptRelevanceReference
"This case report details the pharmacokinetic adjustments of an amrinone infusion in a paediatric patient who developed multiorgan system failure with anuric renal failure and was prescribed continuous arteriovenous haemofiltration."1.29Effect of continuous arteriovenous haemofiltration on pharmacokinetics of amrinone. ( Azin, S; Corddry, D; Lawless, S; Restaino, I, 1993)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lawless, S1
Restaino, I1
Azin, S1
Corddry, D1

Other Studies

1 other study available for amrinone and Multiple Organ Failure

ArticleYear
Effect of continuous arteriovenous haemofiltration on pharmacokinetics of amrinone.
    Clinical pharmacokinetics, 1993, Volume: 25, Issue:1

    Topics: Acute Kidney Injury; Amrinone; Child; Female; Half-Life; Hemofiltration; Humans; Metabolic Clearance

1993